[Advance in hematopoietic and immune reconstitution of allogeneic stem cell transplantation].
作者信息
Huo Y Y, Pang A M, Cheng T
机构信息
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2020 Nov 14;41(11):958-963. doi: 10.3760/cma.j.issn.0253-2727.2020.11.018.
Abstract
摘要
相似文献
1
[Advance in hematopoietic and immune reconstitution of allogeneic stem cell transplantation].[异基因干细胞移植造血与免疫重建的研究进展]
Zhonghua Xue Ye Xue Za Zhi. 2020 Nov 14;41(11):958-963. doi: 10.3760/cma.j.issn.0253-2727.2020.11.018.
2
Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.儿童异基因造血干细胞移植后的体液免疫重建动力学：IgM记忆B细胞的成熟阻滞可能导致抗体免疫重建受损。
Biol Blood Marrow Transplant. 2017 Sep;23(9):1437-1446. doi: 10.1016/j.bbmt.2017.05.005. Epub 2017 May 8.
3
Comparison of Immune Reconstitution After Allogeneic Versus Autologous Stem Cell Transplantation in 182 Pediatric Recipients.182例儿科受者异基因与自体干细胞移植后免疫重建的比较
J Pediatr Hematol Oncol. 2019 Jul;41(5):e302-e307. doi: 10.1097/MPH.0000000000001340.
4
Use of Multivariate Immune Reconstitution Patterns to Describe Immune Reconstitution after Allogeneic Stem Cell Transplantation in Children.应用多元免疫重建模式描述儿童异基因造血干细胞移植后的免疫重建。
Biol Blood Marrow Transplant. 2019 Oct;25(10):2045-2053. doi: 10.1016/j.bbmt.2019.06.018. Epub 2019 Jun 24.
5
Immune Reconstitution in the Aging Host: Opportunities for Mechanism-Based Therapy in Allogeneic Hematopoietic Cell Transplantation.衰老宿主中的免疫重建：同种异体造血细胞移植中基于机制的治疗机会。
Front Immunol. 2021 Apr 19;12:674093. doi: 10.3389/fimmu.2021.674093. eCollection 2021.
6
B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children.儿童造血干细胞移植后 B 细胞重建及影响因素。
Front Immunol. 2019 Apr 12;10:782. doi: 10.3389/fimmu.2019.00782. eCollection 2019.
7
The immune reconstitution of the skin following sex-mismatched allogeneic haematopoietic stem cell transplant: a prospective case series utilizing fluorescence in situ hybridization and immunohistochemistry.性别不匹配的异基因造血干细胞移植后皮肤的免疫重建：一项利用荧光原位杂交和免疫组织化学的前瞻性病例系列研究。
Br J Dermatol. 2018 Jan;178(1):e55-e56. doi: 10.1111/bjd.15878. Epub 2018 Jan 8.
8
Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.异基因干细胞移植后 2 个月 TCRγδ 细胞免疫重建高的患者总生存、无复发生存和移植物抗宿主病发生率降低。
Front Immunol. 2019 Aug 22;10:1997. doi: 10.3389/fimmu.2019.01997. eCollection 2019.
9
Human herpesvirus 6 viremia affects T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.人类疱疹病毒 6 血症影响异基因造血干细胞移植后 T 细胞的重建。
Blood Adv. 2018 Feb 27;2(4):428-432. doi: 10.1182/bloodadvances.2017012724.
10
Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation.低剂量抗胸腺细胞球蛋白对异基因造血细胞移植后免疫重建的影响。
Int J Hematol. 2020 Jan;111(1):120-130. doi: 10.1007/s12185-019-02756-1. Epub 2019 Oct 22.
引用本文的文献
1
[Clinical analysis on the impact of pretransplant iron overload on allogeneic hematopoietic stem cell transplantation for patients with acquired severe aplastic anemia in pediatric].[移植前铁过载对小儿获得性重型再生障碍性贫血患者异基因造血干细胞移植影响的临床分析]
Zhonghua Xue Ye Xue Za Zhi. 2024 Jun 14;45(6):586-590. doi: 10.3760/cma.j.cn121090-20231214-00310.
2
[Key microbial monitoring and clinical analysis of bloodstream infections and CRO colonization after hematopoietic stem cell transplantation in hematological patients].[血液系统疾病患者造血干细胞移植后血流感染及耐碳青霉烯类肠杆菌科细菌定植的关键微生物监测与临床分析]
Zhonghua Xue Ye Xue Za Zhi. 2024 Feb 14;45(2):134-140. doi: 10.3760/cma.j.cn121090-20230731-00040.
3
Clinical characteristics and mortality risk factors of mixed bacterial infections in hematopoietic stem cell transplantation recipients.造血干细胞移植受者混合细菌感染的临床特征和死亡危险因素。
Front Cell Infect Microbiol. 2023 Sep 18;13:1223824. doi: 10.3389/fcimb.2023.1223824. eCollection 2023.
4
Epidemiology, drug resistance analysis and mortality risk factor prediction of gram-negative bacteria infections in patients with allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植患者革兰阴性菌感染的流行病学、耐药性分析及死亡风险因素预测
Heliyon. 2023 Apr 6;9(4):e15285. doi: 10.1016/j.heliyon.2023.e15285. eCollection 2023 Apr.
5
Epidemiology, antimicrobial resistance, and mortality risk factors of carbapenem resistant gram-negative bacteria in hematopoietic stem cell transplantation recipients.造血干细胞移植受者中碳青霉烯类耐药革兰氏阴性菌的流行病学、抗菌药物耐药性和死亡危险因素。
Front Cell Infect Microbiol. 2023 Jan 13;12:1098856. doi: 10.3389/fcimb.2022.1098856. eCollection 2022.
本文引用的文献
1
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States.美国造血细胞移植的当前使用情况及趋势
Biol Blood Marrow Transplant. 2020 Aug;26(8):e177-e182. doi: 10.1016/j.bbmt.2020.04.013. Epub 2020 May 11.
2
Use of Thrombopoietin Receptor Agonists in Prolonged Thrombocytopenia after Hematopoietic Stem Cell Transplantation.促血小板生成素受体激动剂在造血干细胞移植后血小板减少症延长中的应用。
Biol Blood Marrow Transplant. 2020 Mar;26(3):e65-e73. doi: 10.1016/j.bbmt.2019.12.003. Epub 2019 Dec 9.
3
Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation.高剂量全身照射在造血细胞移植前骨髓清除性预处理中的比较。
Biol Blood Marrow Transplant. 2019 Dec;25(12):2398-2407. doi: 10.1016/j.bbmt.2019.08.012. Epub 2019 Aug 29.
4
Prophylactic oral NAC reduced poor hematopoietic reconstitution by improving endothelial cells after haploidentical transplantation.预防口服 NAC 可通过改善单倍体移植后内皮细胞来减少不良的造血重建。
Blood Adv. 2019 Apr 23;3(8):1303-1317. doi: 10.1182/bloodadvances.2018029454.
5
The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells.髓系来源的抑制细胞在抑制移植物抗宿主病的同时保留移植物抗肿瘤活性的机制研究。
Leukemia. 2019 Aug;33(8):2078-2089. doi: 10.1038/s41375-019-0394-z. Epub 2019 Feb 8.
6
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.间充质基质细胞作为患有血液疾病的造血干细胞移植（HSCT）受者急性或慢性移植物抗宿主病的治疗或预防手段。
Cochrane Database Syst Rev. 2019 Jan 30;1(1):CD009768. doi: 10.1002/14651858.CD009768.pub2.
7
Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.使用烟酰胺体外扩增的单个脐血单位进行干细胞移植的 I/II 期研究。
J Clin Oncol. 2019 Feb 10;37(5):367-374. doi: 10.1200/JCO.18.00053. Epub 2018 Dec 4.
8
Expanding Therapeutic Opportunities for Hematopoietic Stem Cell Transplantation: T Cell Depletion as a Model for the Targeted Allograft.拓展造血干细胞移植的治疗机会：以 T 细胞耗竭为例探讨靶向同种异体移植。
Annu Rev Med. 2019 Jan 27;70:381-393. doi: 10.1146/annurev-med-120617-041210. Epub 2018 Oct 25.
9
Mass Cytometry for the Assessment of Immune Reconstitution After Hematopoietic Stem Cell Transplantation.流式细胞术评估造血干细胞移植后免疫重建
Front Immunol. 2018 Jul 26;9:1672. doi: 10.3389/fimmu.2018.01672. eCollection 2018.
10
Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor.外周血造血干细胞移植供者单用粒细胞集落刺激因子（G-CSF）或 G-CSF 联合培非格司亭动员后造血干细胞的细胞成分差异。
Biol Blood Marrow Transplant. 2018 Nov;24(11):2171-2177. doi: 10.1016/j.bbmt.2018.06.023. Epub 2018 Jun 21.
Zotero 插件